GCs downregulate expression of matrix metalloproteinase-9 (MMP-9, a key mediator of extracellular matrix remodeling and BBB disruption) in mouse brain endothelial cells incubated with sera from patients with MS (103, 104). This evidence concerns the gene MMP9 and myeloid sarcoma.